Detalles de la búsqueda
1.
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
Semin Cancer Biol
; 72: 76-89, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881337
2.
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
Breast Cancer Res Treat
; 181(2): 391-401, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323103
3.
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
Cancer Immunol Immunother
; 68(10): 1671-1680, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30905043
4.
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Cancer Immunol Immunother
; 68(1): 57-70, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30276443
5.
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Cancer Immunol Immunother
; 68(11): 1733-1745, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31598757
6.
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.
Clin Immunol
; 195: 28-35, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30025819
7.
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model.
Cancer Immunol Immunother
; 66(12): 1631-1642, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28871365
8.
Prostate cancer vaccines: the long road to clinical application.
Cancer Immunol Immunother
; 64(4): 401-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25690791
9.
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.
Cancer Immunol Immunother
; 64(9): 1123-36, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26026288
10.
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction.
Cancer Immunol Immunother
; 63(11): 1141-50, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25052849
11.
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial.
Cancer Immunol Immunother
; 62(10): 1599-608, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23934022
12.
NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
J Immunol
; 186(6): 3327-35, 2011 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21317394
13.
Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance.
Cancers (Basel)
; 14(24)2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551693
14.
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function.
Cancer Immunol Immunother
; 60(12): 1683-95, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21706285
15.
Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy.
Cancer Immunol Immunother
; 59(5): 715-27, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19904532
16.
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.
Cancer Immunol Immunother
; 59(12): 1781-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20703455
17.
Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design.
Cancers (Basel)
; 12(10)2020 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050520
18.
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer.
Cancers (Basel)
; 12(6)2020 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32570992
19.
Cancer immunotherapy.
Crit Rev Clin Lab Sci
; 46(4): 167-89, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19650714
20.
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Cancer Immunol Immunother
; 58(3): 317-24, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18704409